Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Vir Biotechnology Stock Price, Quotes and Forecasts | NASDAQ:VIR | Benzinga

Q: What sector and industry does Vir Biotechnology (VIR) operate in?

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Vir Biotechnology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VIR.

Open	$5.40
Close	$5.50
Volume / Avg.	713.36K / 1.31M
Day Range	$5.34 - $5.53
52 Wk Range	4.95 - 14.45
Market Cap	$741.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	12%
Days to Cover	7.48

Recent News

Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why

Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate cancer with manageable safety.

Vandana Singh

Vir Biotechnology Stock Soars On Prostate Cancer Trial Data - Here's Why

Vir Biotechnology's Phase 1 trials reveal promising safety and efficacy for dual-masked T-cell engagers targeting HER2 and PSMA in cancer therapies.

Vandana Singh

AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$5.40
Close	$5.50
Volume / Avg.	713.36K / 1.31M
Day Range	$5.34 - $5.53
52 Wk Range	4.95 - 14.45
Market Cap	$741.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	12%
Days to Cover	7.48

About Vir Biotechnology Inc

Sector

Health Care

Industry

Biotechnology

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to tre...

Got Questions? Ask

What is VIR's all-time low price?

What is VIR's drawdown from recent high?

What is VIR's P/E ratio?

What is the consensus rating for VIR?

What is the Pivot support level for VIR?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vir Biotechnology (VIR) stock?

You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.

View our list of the best stock brokerages

Who are Vir Biotechnology (VIR) competitors?

Other companies in Vir Biotechnology’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Vir Biotechnology (VIR) stock?

Vir Biotechnology has a consensus price target of $30.91.

What is the current price for Vir Biotechnology (VIR)?

The stock price for Vir Biotechnology (NASDAQ: VIR) is $5.4102 last updated April 17, 2025 at 5:14 PM EDT.

Does Vir Biotechnology (VIR) pay a dividend?

There are no upcoming dividends for Vir Biotechnology.

When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?

Vir Biotechnology’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Vir Biotechnology (VIR) going to split?

There is no upcoming split for Vir Biotechnology.

What sector and industry does Vir Biotechnology (VIR) operate in?

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Vir Biotechnology Stock Price, Quotes and Forecasts

Vir Biotechnology (VIR) Forecast